Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-OTJKEOIZSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14+,15-,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(1''R,3AR)-1'',3A-di-epi-Perindopril is an epimer (S, RS, SR) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This form of the drug is much less active than the parent compound, perindopril.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9533936
Created by
admin on Sat Dec 16 10:41:55 GMT 2023 , Edited by admin on Sat Dec 16 10:41:55 GMT 2023
|
PRIMARY | |||
|
145513-94-6
Created by
admin on Sat Dec 16 10:41:55 GMT 2023 , Edited by admin on Sat Dec 16 10:41:55 GMT 2023
|
PRIMARY | |||
|
J3VG2W26WZ
Created by
admin on Sat Dec 16 10:41:55 GMT 2023 , Edited by admin on Sat Dec 16 10:41:55 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD